General Information of Drug (ID: DMEMANH)

Drug Name
2-Amino-benzenesulfonamide Drug Info
Synonyms 2-aminobenzenesulfonamide
Cross-matching ID
PubChem CID
72894
ChEBI ID
CHEMBL6705
CAS Number
CAS 3306-62-5
TTD Drug ID
D0OI1H

Consensus Signature of Drug Pharmacogenomic Perturbation (DPP)

Term Name NES FDR q-val Tag % Leading Edge Genes
TGF-beta signaling pathway 1.51 4.74e-1 81/94 (86.17%) THBS1;ID1;FST;...
Yersinia infection 1.40 4.98e-1 120/137 (87.59%) PYCARD;MAP2K6;ITGA4;...
p53 signaling pathway 1.40 4.80e-1 63/73 (86.3%) THBS1;TP53I3;PTEN;...
Hepatitis C 1.39 4.61e-1 139/157 (88.54%) IFIT1;MX1;OAS1;...
Alcoholism 1.39 4.53e-1 86/186 (46.24%) PRKACB;GNAS;NTRK2;...
Th17 cell differentiation 1.37 4.80e-1 95/107 (88.79%) TGFBR2;PRKCQ;IL2RG;...
Hedgehog signaling pathway 1.34 4.94e-1 43/56 (76.79%) PRKACB;SCUBE2;SMURF2;...
Salmonella infection 1.33 4.97e-1 198/249 (79.52%) PAK1;PYCARD;PODXL;...
Herpes simplex virus 1 infection 1.33 4.84e-1 165/498 (33.13%) BST2;CCL5;OAS1;...
Chagas disease 1.32 4.84e-1 93/102 (91.18%) TGFBR2;GNAS;CCL5;...
Natural killer cell mediated cytotoxicity 1.32 4.74e-1 99/131 (75.57%) PAK1;BID;LCP2;...
Cocaine addiction 1.31 4.64e-1 42/49 (85.71%) PRKACB;GNAS;JUN;...
Pathogenic Escherichia coli infection 1.31 4.56e-1 152/197 (77.16%) PAK1;PYCARD;F2R;...
Sphingolipid signaling pathway 1.30 4.71e-1 106/119 (89.08%) DEGS1;PTEN;BID;...
Regulation of lipolysis in adipocytes 1.29 4.62e-1 52/55 (94.55%) CGA;PRKACB;GNAS;...
Epstein-Barr virus infection 1.29 4.54e-1 189/202 (93.56%) ISG15;MAP2K6;OAS1;...
Fc gamma R-mediated phagocytosis 1.29 4.49e-1 79/97 (81.44%) PAK1;CRK;ARPC1B;...
Hepatitis B 1.28 4.67e-1 151/162 (93.21%) TGFBR2;MAP2K6;BID;...
Inflammatory mediator regulation of TRP channels 1.27 4.87e-1 82/98 (83.67%) PRKCQ;PRKACB;MAP2K6;...
Pancreatic cancer 1.26 4.87e-1 75/76 (98.68%) TGFBR2;TGFA;E2F3;...
Human cytomegalovirus infection 1.26 4.81e-1 201/225 (89.33%) CXCL12;PRKACB;MAP2K6;...
Neurotrophin signaling pathway 1.26 4.79e-1 107/119 (89.92%) CRK;NTRK2;ARHGDIA;...
Chronic myeloid leukemia 1.24 5.00e-1 72/76 (94.74%) TGFBR2;CRK;E2F3;...
ErbB signaling pathway 1.24 4.98e-1 79/85 (92.94%) PAK1;TGFA;CBLB;...
Type I diabetes mellitus 1.24 4.94e-1 38/43 (88.37%) PTPRN2;HLA-DQA1;HLA-DPB1;...
Relaxin signaling pathway 1.24 4.89e-1 114/129 (88.37%) TGFBR2;PRKACB;GNAS;...
Ribosome biogenesis in eukaryotes 1.24 4.84e-1 52/108 (48.15%) NVL;HEATR1;POP5;...
Regulation of actin cytoskeleton 1.23 4.84e-1 185/218 (84.86%) PAK1;F2R;CXCL12;...
Primary bile acid biosynthesis 1.23 4.85e-1 15/17 (88.24%) AMACR;ACOX2;ACOT8;...
Human papillomavirus infection 1.22 5.02e-1 284/331 (85.8%) THBS1;THBS2;HEY1;...
Synaptic vesicle cycle -1.33 3.19e-1 63/78 (80.77%) ATP6V0A4;STX1A;DNM1;...
Glycerophospholipid metabolism -1.34 3.18e-1 71/98 (72.45%) CHKB;PLA2G2D;PLD1;...
alpha-Linolenic acid metabolism -1.34 3.21e-1 17/25 (68%) PLAAT3;ACAA1;FADS2;...
Transcriptional misregulation in cancer -1.35 3.23e-1 158/192 (82.29%) KMT2A;CEBPB;HDAC1;...
Central carbon metabolism in cancer -1.39 2.88e-1 67/70 (95.71%) PIK3CB;LDHC;HK3;...
Metabolism of xenobiotics by cytochrome P450 -1.42 2.35e-1 49/77 (63.64%) GSTM3;CYP2D6;CYP1B1;...
Amoebiasis -1.43 2.37e-1 99/102 (97.06%) LAMB2;ITGB2;COL1A2;...
Neutrophil extracellular trap formation -1.43 2.40e-1 101/189 (53.44%) PLCB3;FCGR2A;AGER;...
Steroid hormone biosynthesis -1.44 2.30e-1 43/61 (70.49%) CYP3A7;CYP3A5;SRD5A1;...
Dilated cardiomyopathy -1.46 2.15e-1 86/96 (89.58%) ATP2A3;SGCA;CACNA1D;...
Maturity onset diabetes of the young -1.47 1.99e-1 21/26 (80.77%) SLC2A2;ONECUT1;MNX1;...
Selenocompound metabolism -1.49 1.81e-1 11/17 (64.71%) PAPSS1;CTH;SEPHS1;...
Ether lipid metabolism -1.50 1.86e-1 32/49 (65.31%) PLA2G4A;PAFAH1B1;PLA2G12A;...
Cardiac muscle contraction -1.50 1.96e-1 64/87 (73.56%) RYR2;ATP1B1;COX6A1;...
Insulin resistance -1.50 2.06e-1 96/108 (88.89%) INS;IRS1;SREBF1;...
Fructose and mannose metabolism -1.52 1.90e-1 30/33 (90.91%) ALDOB;TKFC;HK2;...
Carbohydrate digestion and absorption -1.52 2.03e-1 37/47 (78.72%) SLC2A2;ATP1B1;SLC5A1;...
Porphyrin and chlorophyll metabolism -1.53 2.04e-1 23/43 (53.49%) COX10;CP;FECH;...
African trypanosomiasis -1.53 2.14e-1 32/37 (86.49%) ICAM1;IL10;LAMA4;...
Arrhythmogenic right ventricular cardiomyopathy -1.55 2.11e-1 70/77 (90.91%) ATP2A3;SGCA;CACNA1D;...
Ferroptosis -1.58 1.80e-1 36/41 (87.8%) CP;MAP1LC3B;ATG7;...
Vitamin digestion and absorption -1.59 1.67e-1 17/24 (70.83%) PNLIP;ABCC1;SLC19A2;...
Starch and sucrose metabolism -1.62 1.43e-1 25/36 (69.44%) PYGM;PYGB;HK2;...
Pancreatic secretion -1.65 1.20e-1 87/102 (85.29%) ADCY9;PLA2G2D;KCNMA1;...
Fat digestion and absorption -1.66 1.22e-1 35/43 (81.4%) PNLIP;PLA2G12A;CLPS;...
Renin-angiotensin system -1.74 6.37e-2 20/23 (86.96%) MME;KLK1;ANPEP;...
Retinol metabolism -1.74 7.52e-2 41/68 (60.29%) CYP3A7;CYP3A5;AOX1;...
Type II diabetes mellitus -1.77 7.67e-2 42/46 (91.3%) SOCS2;PIK3CB;HK3;...
Hypertrophic cardiomyopathy -1.81 7.08e-2 81/90 (90%) ATP2A3;SGCA;CACNA1D;...
Protein digestion and absorption -1.86 7.96e-2 78/103 (75.73%) COL4A4;ATP1B1;COL9A3;...
×

Pharmacogenomic Perturbation Across Diseases and Tissues

Breast
Breast adenocarcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
MCF7 CVCL_0031 Homo sapiens 10uM 6H, 24H
Prostate
Prostate carcinoma
Cell Line Name Cellosaurus Accession Species of Origin Drug Dosage Time Point Details
PC-3 CVCL_0035 Homo sapiens 10uM 6H, 24H